Cutaneous anaplastic large-cell lymphoma with dramatic response to brentuximab vedotin; [Brentuximab vedotine dramatik yanıtlı kutanöz anaplastik büyük hücreli lenfoma]
No Thumbnail Available
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
[No abstract available]
Description
Keywords
Aged, 80 and over , Antineoplastic Agents, Immunological , Brentuximab Vedotin , Female , Humans , Lymphoma, Large-Cell, Anaplastic , Skin , Skin Neoplasms , Treatment Outcome , anastrozole , brentuximab vedotin , lactate dehydrogenase , brentuximab vedotin , immunological antineoplastic agent , aged , anaplastic large cell lymphoma , bone lesion , bone marrow biopsy , breast carcinoma , breast disease , breast imaging reporting and data system , breast nodule , breast tumor , cancer regression , case report , cell infiltration , clinical article , daily life activity , erythema , erythematous plaque , face injury , female , frailty , hemoglobin blood level , histopathology , human , Letter , loss of appetite , mammography , monotherapy , multiple cycle treatment , positron emission tomography-computed tomography , skin defect , treatment response , ulcer , very elderly , weakness , anaplastic large cell lymphoma , pathology , skin , skin tumor , treatment outcome